University of Sheffield UK - Department of Neuroscience
Faculty: Faculty of Medicine, Dentistry and Health Contract Type: Fixed-term for three years Working Pattern: Full Time Salary: Grade 7, £28,685 to £36,298 per annum with potential to progress to £39,649 Job Reference Number: UOS007813
We are seeking a highly motivated scientist to carry out research projects in Translational Cerebrovascular Disease. We are exploring innovative cerebroprotection strategies with the central purpose of developing novel clinical therapies for devastating vascular diseases of the brain. You will have an excellent research and publication track record and will contribute to the work of an internationally recognised research group. You must possess excellent organisation skills and the ability to interact well within a group. You should be qualified to PhD level (or equivalent) in Neuroscience or Biological Sciences and have experience and interest in translational research. You will use in vivo and in vitro approaches to determine the molecular and cellular pathways that underlie preconditioning and cerebroprotection in the brain. We have already identified candidate pathways but these require further elucidation. After elucidation, pharmacological manipulation of the most ‘promising’ pathway would be the next step with the aim of developing a clinical therapy. Expertise with cell culture (neuronal and astrocytic) and focal ischaemia models of stroke would be a considerable advantage To apply for this role, please contact Professor Majid
Closing Date: 9 October 2013
Professor Arshad Majid majidarshad@msn.com Professor of Cerebrovascular Neurology Sheffield Institute for Translational Neuroscience (SITraN) University of Sheffield 385A Glossop Road SHEFFIELD S10 2HQ
We offer thirteen PhD positions (Early Stage Researcher) for three years to undertake research in neuroinflammation. This research is supported by the Marie Curie Initial Training Network (ITN) “nEUROinflammation” within the EU Seventh Framework Programme for Research and Technological Development (2007-2013). The scientific goal of nEUROinflammation is to investigate inflammatory mechanisms in stroke and multiple sclerosis with a special focus on bone-marrow derived macrophages, dendritic cells, the endothelium, and microglia. A unique feature of our consortium is to combine stroke and MS research in order to release synergies between the fields and to provide PhD students with a comprehensive picture of neuroinflammation. By employing a range of experimental and translational techniques, this ITN aims at one goal: to modulate basic neuroinflammatory mechanisms for the treatment of neurological diseases.
The PhD students will be hosted by 16 academic or industrial partner organizations in Germany, Italy, France, Spain, Finland, Poland, Netherlands, and Switzerland. For additional job details and the main activities in each project of nEUROinflammation, please follow the link www.neuroinflammation.eu... (lire la suite)
Le prix de thèse de cette année a été remis à Magalie Fréchou lors du colloque annuel de la SCMC qui s'est tenu à Paris le 12 février 2013... (lire la suite)
Le colloque 2013 de la société vous accueillera à Paris le 12 février 2013 qui sera l'occasion de vous écouter et de discuter ensemble de vos derniers travaux. Par ailleurs, les conférences plénières permettront d'aborder le thème des maladies cérébrovasculaires et des troubles psychiatriques au travers de 2 conférences plénières présentées par Isabelle LOUBINOUX (DR INSERM, Toulouse) sur le thème "Les inhibiteurs de recapture de la sérotonine améliorent la récupération fonctionnelle après un accident vasculaire cérébral" et Annie ANDRIEUX (DR CEA, Grenoble) sur le thème "Souris déficientes pour MAP6/STOP: un modèle expérimental de troubles neuro-développementaux reliés à la schizophrénie".
voici le programme définitif (cf le document lié). .. (lire la suite)
A postdoctoral position is available in the laboratory of Jerome Badaut, Ph.D., interested in the neurovascular and blood-brain barrier dysfunctions after brain injuries. This position is part of a NIH funded project involving the potential therapeutic effects of a JNK inhibitor and silencing RNA targeting Aquaporin 4 in juvenile traumatic brain injury. The ideal candidate would be a recent Ph.D. or M.D./Ph.D. with a background in rat or mice TBI model surgeries and/or some experience with immunohistochemistry and western blot. The candidate will also be expected to work effectively with graduate and undergraduate students. Detailed information can be found at http://www.llu.edu/medicine/basic-sciences/faculty/physiology/badaut-jerome.page
Interested scientists should send a CV, list of references, and cover letter to jbadaut@llu.edu
